0001225208-13-013159.txt : 20130523 0001225208-13-013159.hdr.sgml : 20130523 20130523171947 ACCESSION NUMBER: 0001225208-13-013159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130523 FILED AS OF DATE: 20130523 DATE AS OF CHANGE: 20130523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Caforio Giovanni CENTRAL INDEX KEY: 0001533201 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 13869361 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: ROUTE 206 & PROVINCELINE ROAD CITY: LAWRENCEVILLE STATE: NJ ZIP: 08543 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 doc4.xml X0306 4 2013-05-23 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001533201 Caforio Giovanni BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 Pres., US Pharmaceuticals Common Stock, $0.10 par value 2013-05-23 4 M 0 21333.0000 25.4500 A 84501.2190 D Common Stock, $0.10 par value 2013-05-23 4 S 0 26647.0000 46.2900 D 57854.2190 D Option (right to buy) 25.4500 2013-05-23 4 M 0 21333.0000 0.0000 D 2015-02-28 Common Stock, $0.10 par value 21333.0000 0.0000 D The reporting person sold 17,913 shares to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions upon the exercise of the option. The remaining 8,734 shares sold were held by the reporting person for more than a year. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.22 to $46.46, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 1, 2005. /s/ Robert J. Wollin, attorney-in-fact for Giovanni Caforio 2013-05-23